🇺🇸 FDA
Pipeline program

VYEPTI 100 mg concentrate for solution for infusion

19140A

Phase 3 small_molecule active

Quick answer

VYEPTI 100 mg concentrate for solution for infusion for Chronic migraine is a Phase 3 program (small_molecule) at H. Lundbeck A/S with 1 ClinicalTrials.gov record(s).

Program details

Company
H. Lundbeck A/S
Indication
Chronic migraine
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials